Randomised controlled trials in cardiovascular medicine: Past achievements, future challenges

British Medical Journal

Volumn 319, Issue 7209, 1999, Pages 564-568

  Yusuf, Salim ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEVELOPING COUNTRY; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; HYPOTHESIS; METHODOLOGY; PREVENTIVE MEDICINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCIENCE;

EID: 0033612837     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.319.7209.564     Document Type: Article

References (29)

1. 1 Friedman LM, Furberg C, DeMets DL. Fundamentals of clinical trial, 3rd ed. St Louis, MS: Mosby, 1996.
2. 2 Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1-39.
3. 3 Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 1976;34:585-612.
4. 4 Pogue J, Yusuf S. Overcoming the limitations of current meta-analysis of randomised controlled trials. Lancet 1998;351:47-52.
5. 5 Yusuf S, Collins R, Peto R. Why do we need some large, simple randomized trials? Stats Med 1984;3:409-20.
6. 6 Meldrum M. "A calculated risk:" the Salk polio vaccine field trials of 1954. BMJ 1998;317:1233-6.
7. 7 ISIS-1 (First International Study of Infant Survival) Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1, Lancet 1986;i:57-66.
8. 8 GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocadico). Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet 1987;ii:871-4.
9. 9 Flather MD, Farkouh ME, Yusuf S. Large simple trials in cardiovascular disease: their impact on medical practice. In: Califf RM, Mark B, Wagner GS, eds. Acute coronary care. St Lonis, MS: Mosby, 1995;131-44.
10. 10 The SOLVD (studies of left ventricular dysfunction) Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
11. 11 The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33.
12. 12 The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-57.
13. 13 The Heart Outcomes Prevention Evaluation Study Investigators. The HOPE (heart outcomes prevention evaluation) study: the design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. Can J Cardiol 1996;12:127-37.
14. 14 Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing physicians' health study. N Engl J Med 1989;321:129-35.
15. 15 Rodgers A, MacMahon S, Gamble G, Slattery J, Sandercock P, Warlow C for the United Kingdom Transient Ischaemic Attack Collaborative Group. Blood pressure and risk of stroke in patients with cerebrovascular disease. BMJ 1996;313:147.
16. 16 Tardif JC, Cote G, Lesperance J, Bourassa M, Lambert J, Doucet S, et al on behalf of the Multivitamins and Probucol Study Group. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med 1997;337:365-72.
17. 17 ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: ISIS 2. Lancet 1988;i:349-60.
18. 18 A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. N Eng J Med 1997;336:1621-8.
19. 19 Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-71.
20. 20 Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
21. 21 Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. II: maintenance of vascular graft of arterial patency by antiplatelet therapy. BMJ 1994;308:159-68.
22. 22 Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994;308:235-46.
23. 23 Yusuf S, Collins R, Peto R, Furberg C, Stampfer MJ, Goldhaber SZ, et al. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J 1985;6:556-85.
24. 24 Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1991;343:311-22.
25. 25 Teo KK, Yusuf S, Collins R, Held PH, Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ 1991;303:1499-503.
26. 26 ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-85.
27. 27 Yusuf S, Held P, Teo KK, Toretsky ER. Selection of patients for randomized controlled trials: implications of wide or narrow eligibility criteria. Stats Med 1990;9:73-86.
28. 28 Montague T, Montague P, Dzavik V, Teo K for the Clinical Quality Improvement Network (CQIN) Investigators. The promise and practice of cardiovascular risk reduction: a disease management perspective. Can J Cardiol 1996;12:995-9.
29. 29 Reddy KS, Yusuf S. Emeging epidemic of cardiovascular disease in developing countries. Circulation 1998;97:596-601. (Accepted 30 April 1999)